Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
29,511,049
-
Share change
-
-605,460
-
Total reported value
-
$901,638,399
-
Put/Call ratio
-
476%
-
Price per share
-
$30.55
-
Number of holders
-
112
-
Value change
-
-$18,873,506
-
Number of buys
-
56
-
Number of sells
-
43
Institutional Holders of GENOMIC HEALTH INC - COM (GHDX) as of Q1 2015
As of 31 Mar 2015,
GENOMIC HEALTH INC - COM (GHDX) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,511,049 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Camber Capital Management LLC, BAILLIE GIFFORD & CO, NORTH TIDE CAPITAL, LLC, VANGUARD GROUP INC, Champlain Investment Partners, LLC, STATE STREET CORP, BlackRock Fund Advisors, FMR LLC, and BlackRock Institutional Trust Company, N.A..
This page lists
112
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.